Table 1.
Demographic, clinical and actigraphic characteristics of children with moderate to severe atopic dermatitis.
Patient characteristics | (n = 10) | |
---|---|---|
Age (years) | 5.87 ± 5.34 | |
Gender, male | 5 (50%) | |
SCORAD severity | Severe | 9 (90%) |
Moderate | 1 (10%) | |
POEM | ||
Mild eczema | 1 (10.0%) | |
Moderate eczema | 2 (20.0%) | |
Severe eczema | 7 (70.0%) | |
CDLQI | ||
Small effect | 3 (30.0%) | |
Moderate effect | 3 (30.0%) | |
Very large effect | 1 (10.0%) | |
Extremely large effect | 3 (30.0%) | |
Allergic comorbidity | 5 (41.7%) | |
n (%) | Food allergy | |
Allergic rhinitis | 5 (41.7%) | |
Asthma | 4 (33.3%) | |
Brief Infant Sleep Questionnaire | ||
Time to bed, mean ± SD | 21:29 ± 01:30 | |
Nocturnal sleep hours, mean ± SD | 6.85 ± 1.33 | |
Daytime sleep hours, mean ± SD | 1.40 ± 1.17 | |
Night awakenings, mean ± SD | 3.60 ± 4.38 | |
Nocturnal wakefulness (hours), mean ± SD | 1.89 ± 1.65 | |
Sleep-onset time, mean ± SD | 0.45 ± 0.35 | |
Actigraphy | ||
Nocturnal sleep hours, mean ± SD | 8.89 ± 1.07 | |
Nocturnal sleep diagnosis | Decreased | 8 (88.9%) |
n (%) | Mildly decreased | 1 (11.1%) |
Nocturnal sleep efficiency (%), mean ± SD | 86 ± 6 | |
Nocturnal sleep efficiency diagnosis (%) | Normal range | 5 (50%) |
Low | 5 (50%) | |
Night awakenings, mean ± SD | 11.28 ± 2.83 | |
Night awakenings diagnosis, n (%) | Increased | 9 (100%) |
Normal | 1 (10%) |